A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
KaliVir Immunotherapeutics
Nuvectis Pharma, Inc.
Takeda
Novartis
Dana-Farber Cancer Institute
Cancer Research UK
Quadriga Biosciences, Inc.
National Institutes of Health Clinical Center (CC)
Novartis
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Valerio Therapeutics
Valerio Therapeutics
Children's Oncology Group
University of Chicago
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center